Pharmacokinetics, bioavailability, and bioequivalence of lower‐sodium oxybate in healthy participants in two open‐label, randomized, crossover studies

por Chen, Cuiping, Jenkins, Jack, Zomorodi, Katie, Skowronski, Roman
Publicado 2021

Single‐Dose Pharmacokinetics and Safety of Solriamfetol in Participants With Normal or Impaired Renal Function and With End‐Stage Renal Disease Requiring Hemodialysis

por Zomorodi, Katie, Chen, Dan, Lee, Lawrence, Lasseter, Kenneth, Marbury, Thomas
Publicado 2019

A Randomized, Double‐Blind, Placebo‐ and Positive‐Controlled, 4‐Period Crossover Study of the Effects of Solriamfetol on QTcF Intervals in Healthy Participants

por Zomorodi, Katie, Chen, Dan, Lee, Lawrence, Swearingen, Dennis, Carter, Lawrence P.
Publicado 2020

Pharmacokinetic profile of defibrotide in patients with renal impairment

por Tocchetti, Paola, Tudone, Elena, Marier, Jean-Francois, Marbury, Thomas C, Zomorodi, Katie, Eller, Mark
Publicado 2016

Population Pharmacokinetic Model Development and Simulation for Recombinant Erwinia Asparaginase Produced in Pseudomonas fluorescens (JZP‐458)

por Lin, Tong, Dumas, Todd, Kaullen, Josh, Berry, N. Seth, Choi, Mi Rim, Zomorodi, Katie, Silverman, Jeffrey A.
Publicado 2021

Population and Noncompartmental Pharmacokinetics of Sodium Oxybate Support Weight‐Based Dosing in Children and Adolescents With Narcolepsy With Cataplexy

por Chen, Cuiping, Rosen, Carol L., Ruoff, Chad, Boyce, Leslie H., Parvataneni, Rupa, Zomorodi, Katie, Brantley, Scott, Sale, Mark, Plazzi, Giuseppe
Publicado 2020

Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof‐of‐Concept Trial

por Videnovic, Aleksandar, Amara, Amy W., Comella, Cynthia, Schweitzer, Paula K., Emsellem, Helene, Liu, Kris, Sterkel, Amanda L., Gottwald, Mildred D., Steinerman, Joshua R., Jochelson, Philip, Zomorodi, Katie, Hauser, Robert A.
Publicado 2021